You've probably heard of GLP-1 the hormone behind Ozempic and Wegovy
Following the publication of the guidelines, criticism and questions have emerged
I'm fascinated by this topic
This can make it difficult to get coverage for GLP-1 medications unless they are prescribed for another condition, such as diabetes
According to their survey, individuals taking GLP-1 drugs for weight loss show a significantly larger reduction in their consumption of snacks, sugary drinks, baked goods, and confectionary compared to non GLP-1 users
Importantly, SNAC transiently fluidizes the gastric epithelial membrane, promoting transcellular absorption of semaglutide while preserving tight junction integrity